Disruptions and Innovations: A Global Overview of Healthcare Challenges

Health systems worldwide brace against challenges as U.S. tariffs threaten pharmaceutical supply chains. The Swiss pharmaceutical association interpharma expressed concern over the 100% tariffs imposed by the U.S., urging Swiss authorities to negotiate tariffs akin to Britain's, which secured tariff-free access.

A landmark study challenges the age barrier in treating early-stage lung cancer. Researchers in The Lancet Regional Health details how patients over 80 years of age might still undergo safe, potentially curative surgeries, reshaping future clinical guidelines.

In a groundbreaking initiative, the U.S. EPA and HHS are set to monitor drinking water for microplastics and pharmaceuticals. This effort aligns with the Trump administration's health agenda and sets the stage for potential regulatory changes addressing emerging health risks.